Received Feb 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5G23D | — |
Kinrix was administered to a 4-month-old patient instead of Pediarix; Kinrix was administered to a 4-month-old patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 4-month-old female patient who received DTPa-IPV (Kinrix) (batch number 5G23D, expiry date 21-AUG-2026) for prophylaxis. Co-suspect products included DTPa-HBV-IPV (Pediarix) for prophylaxis. On 27-JAN-2025, the patient received Kinrix. On an unknown date, the patient did not receive Pediarix. On 27-JAN-2025, an unknown time after receiving Kinrix and Pediarix, the patient experienced wrong vaccine administered (Verbatim: Kinrix was administered to a 4-month-old patient instead of Pediarix) and inappropriate age at vaccine administration (Verbatim: Kinrix was administered to a 4-month-old patient). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 06-FEB-2025 The Healthcare professional reported that Kinrix was administered to a 4 month old patient instead of Pediarix, which led to wrong vaccine administered and inappropriate age at vaccine administration. She stated they had always revaccinated after 30 days because it was considered an invalid dose but their nurse stated, they did not had to revaccinate because it was the same dose. The Vaccine Administration Facility is the same as Primary Reporter.